Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Exchange Rate Effect (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Exchange Rate Effect for 10 consecutive years, with -$17000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 45.16% to -$17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $36000.0, a 216.13% increase, with the full-year FY2025 number at $36000.0, up 216.13% from a year prior.
  • Exchange Rate Effect was -$17000.0 for Q4 2025 at Ekso Bionics Holdings, down from -$10000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $56000.0 in Q2 2025 to a low of -$35000.0 in Q1 2021.
  • A 5-year average of $526.32 and a median of -$1000.0 in 2022 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 275.0% in 2024, then plummeted 1100.0% in 2025.
  • Ekso Bionics Holdings' Exchange Rate Effect stood at $41000.0 in 2021, then crashed by 43.9% to $23000.0 in 2022, then plummeted by 186.96% to -$20000.0 in 2023, then tumbled by 55.0% to -$31000.0 in 2024, then surged by 45.16% to -$17000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Exchange Rate Effect are -$17000.0 (Q4 2025), -$10000.0 (Q3 2025), and $56000.0 (Q2 2025).